Our Corporate Partners

The International PNH Interest Group is a recognized by the US Internal Revenue Service as a not-for-profit organization. We are grateful to our Corporate Partners, who support our work.

Founding Partner

Alexion Pharmaceuticals

http://www.alxn.com

Gold Partners

Apellis Pharmaceuticals, Inc.

http://www.apellis.com

Regeneron Pharmaceuticals, Inc.

https://www.regeneron.com

Silver Partners

BioCryst Pharmaceuticals, Inc.

http://www.biocryst.com/

F. Hoffmann-La-Roche

https://www.roche.com/

Bronze Partner

Omeros Corporation

https://www.omeros.com

If you have questions about or are interested in becoming a corporate partner and supporting our work, please contact us. Corporate membership is open to pharmaceutical and biotechnology companies interested or engaged in PNH research.

Representatives from investment and venture capital firms are not eligible for membership, given that IPIG is a not-for-profit scientific/educational organization whose purpose is to promulgate knowledge about and advocate for appropriate treatment and care of persons living with PNH.

Help us expand our Resources

If you have information or resources you’d like to submit for inclusion on our IPIG website, our board will be happy to consider your submission.

Find out how to submit a resource